It has been suggested that CPEB4 gene expression is directly proportional to the pathological degree of glioma, increased CPEB4 gene expression in primary tumors in predicting poor outcomes in patients, and suppressed CPEB4 gene expression inhibits tumor cell proliferation and is a potential therapeutic target for glioblastoma [32]. The gene discussed is CPEB4; the disease is neoplasm.